i was on that prr ride too to 20c.
but to me the difference between ADO and PRR or many other bio companies is
- ADO can have many positive news coming in (ie. deals after deals) in a short period of time
it is already mentioned in recent presentation
1. Currently 2-3 healthcare R&D companies actively considering Mix&Go? - short term revenue opportunities as R&D companies take less time on approval processes
2. ADO is currently working on supply agreements with leading global IVD players
from the above i do see at least 4 deals being ironed out this year.
my chartist friends, page-2
Add ADO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $67.22M | |||
| Open | High | Low | Value | Volume |
| 2.7¢ | 2.9¢ | 2.7¢ | $17.68K | 634.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 541015 | 2.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.9¢ | 4693635 | 4 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| ADO (ASX) Chart |